351 related articles for article (PubMed ID: 22329799)
1. Role and function of macrophages in the metabolic syndrome.
Bhargava P; Lee CH
Biochem J; 2012 Mar; 442(2):253-62. PubMed ID: 22329799
[TBL] [Abstract][Full Text] [Related]
2. Adipose tissue macrophages.
Zeyda M; Stulnig TM
Immunol Lett; 2007 Oct; 112(2):61-7. PubMed ID: 17719095
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptors, inflammation, metabolism and obesity.
Fresno M; Alvarez R; Cuesta N
Arch Physiol Biochem; 2011 Jul; 117(3):151-64. PubMed ID: 21599616
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic role of scavenger receptor CD36 in the metabolic syndrome and diabetes.
Kennedy DJ; Kashyap SR
Metab Syndr Relat Disord; 2011 Aug; 9(4):239-45. PubMed ID: 21428745
[TBL] [Abstract][Full Text] [Related]
6. Immunometabolism of AMPK in insulin resistance and atherosclerosis.
Fullerton MD; Steinberg GR; Schertzer JD
Mol Cell Endocrinol; 2013 Feb; 366(2):224-34. PubMed ID: 22361321
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory mediators involved in the progression of the metabolic syndrome.
Ma K; Jin X; Liang X; Zhao Q; Zhang X
Diabetes Metab Res Rev; 2012 Jul; 28(5):388-94. PubMed ID: 22389088
[TBL] [Abstract][Full Text] [Related]
8. The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA.
Oliver E; McGillicuddy F; Phillips C; Toomey S; Roche HM
Proc Nutr Soc; 2010 May; 69(2):232-43. PubMed ID: 20158940
[TBL] [Abstract][Full Text] [Related]
9. Ceramides in insulin resistance and lipotoxicity.
Summers SA
Prog Lipid Res; 2006 Jan; 45(1):42-72. PubMed ID: 16445986
[TBL] [Abstract][Full Text] [Related]
10. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
Black PH
Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
[TBL] [Abstract][Full Text] [Related]
11. Innate immunity, macrophage activation, and atherosclerosis.
Yan ZQ; Hansson GK
Immunol Rev; 2007 Oct; 219():187-203. PubMed ID: 17850490
[TBL] [Abstract][Full Text] [Related]
12. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes.
Esser N; Legrand-Poels S; Piette J; Scheen AJ; Paquot N
Diabetes Res Clin Pract; 2014 Aug; 105(2):141-50. PubMed ID: 24798950
[TBL] [Abstract][Full Text] [Related]
13. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha.
Suganami T; Nishida J; Ogawa Y
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2062-8. PubMed ID: 16123319
[TBL] [Abstract][Full Text] [Related]
14. From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation.
Lionetti L; Mollica MP; Lombardi A; Cavaliere G; Gifuni G; Barletta A
Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):146-52. PubMed ID: 19171470
[TBL] [Abstract][Full Text] [Related]
15. Inflammation-mediated obesity and insulin resistance as targets for nutraceuticals.
Kim MS; Lee MS; Kown DY
Ann N Y Acad Sci; 2011 Jul; 1229():140-6. PubMed ID: 21793849
[TBL] [Abstract][Full Text] [Related]
16. Impact of periodontitis on the diabetes-related inflammatory status.
Santos Tunes R; Foss-Freitas MC; Nogueira-Filho Gda R
J Can Dent Assoc; 2010; 76():a35. PubMed ID: 20831852
[TBL] [Abstract][Full Text] [Related]
17. Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation.
Wolfs IM; Donners MM; de Winther MP
Thromb Haemost; 2011 Nov; 106(5):763-71. PubMed ID: 21947328
[TBL] [Abstract][Full Text] [Related]
18. Lipotoxicity in macrophages: evidence from diseases associated with the metabolic syndrome.
Prieur X; Roszer T; Ricote M
Biochim Biophys Acta; 2010 Mar; 1801(3):327-37. PubMed ID: 19796705
[TBL] [Abstract][Full Text] [Related]
19. Meta-Inflammation and Metabolic Reprogramming of Macrophages in Diabetes and Obesity: The Importance of Metabolites.
Russo S; Kwiatkowski M; Govorukhina N; Bischoff R; Melgert BN
Front Immunol; 2021; 12():746151. PubMed ID: 34804028
[TBL] [Abstract][Full Text] [Related]
20. The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease.
Martínez-Clemente M; Clària J; Titos E
Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):347-53. PubMed ID: 21587068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
